and best-corrected distance visual acuity (BCDVA; logMAR) were examined with a Standard Logarithmic Visual Acuity E chart (Snellen) preoperatively and at 1week, 3 months, and 6 months postoperatively.
Susvimo is also approved to treat age-related macular degeneration, and the medication, ranibizumab, is delivered though a ...
The primary endpoint of the study is a change in best-corrected visual acuity score (the best distance vision a person can ...
Background/aim To quantify the impact of baseline presenting visual ... 9. Distance presenting VA was measured separately for each eye, with and without spectacles, if worn, using a logarithm of the ...
Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...
Objective: This study aims to compare the binocular visual functions and balance among monocular ... to focus on the line second from the bottom on a reduced vision chart at a distance of ...
Background/aims To evaluate baseline low-luminance visual acuity (LLVA) as a predictor of visual acuity ... followed immediately by LLVA measurement (both using ETDRS charts at a distance of 4 m).
Subjects in the study were able to gain three lines of near visual acuity on a standard eye chart compared to placebo, without losing more than one line for distance vision. Pilocarpine is already ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback